0001377490 2006-09-05 0001377490 us-gaap:CommonStockMember 2006-09-05 0001377490 us-gaap:AdditionalPaidInCapitalMember 2006-09-05 0001377490 us-gaap:RetainedEarningsMember 2006-09-05 0001377490 2006-12-31 0001377490 us-gaap:CommonStockMember 2006-12-31 0001377490 us-gaap:CommonClassAMember 2006-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2006-12-31 0001377490 us-gaap:RetainedEarningsMember 2006-12-31 0001377490 2006-09-06 2006-12-31 0001377490 us-gaap:CommonStockMember 2006-09-06 2006-12-31 0001377490 us-gaap:CommonClassAMember 2006-09-06 2006-12-31 0001377490 us-gaap:CommonClassAMember 2006-09-06 2006-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2006-09-06 2006-12-31 0001377490 us-gaap:RetainedEarningsMember 2006-09-06 2006-12-31 0001377490 pina:ReverseStockSplitMember 2007-02-19 0001377490 pina:ReverseStockSplitMember 2007-02-20 0001377490 2007-04-19 0001377490 pina:AfterConsummatingOfferingMember 2007-04-25 0001377490 2007-04-01 2007-04-30 0001377490 us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFeesMember 2007-04-01 2007-04-30 0001377490 2007-01-01 2007-12-31 0001377490 us-gaap:CommonStockMember 2007-01-01 2007-12-31 0001377490 us-gaap:CommonClassAMember 2007-01-01 2007-12-31 0001377490 us-gaap:CommonClassAMember 2007-01-01 2007-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2007-01-01 2007-12-31 0001377490 us-gaap:RetainedEarningsMember 2007-01-01 2007-12-31 0001377490 2007-12-31 0001377490 us-gaap:CommonStockMember 2007-12-31 0001377490 us-gaap:CommonClassAMember 2007-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2007-12-31 0001377490 us-gaap:RetainedEarningsMember 2007-12-31 0001377490 2008-01-01 2008-12-31 0001377490 us-gaap:CommonStockMember 2008-01-01 2008-12-31 0001377490 us-gaap:CommonClassAMember 2008-01-01 2008-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2008-01-01 2008-12-31 0001377490 us-gaap:RetainedEarningsMember 2008-01-01 2008-12-31 0001377490 2008-12-31 0001377490 us-gaap:CommonStockMember 2008-12-31 0001377490 us-gaap:CommonClassAMember 2008-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2008-12-31 0001377490 us-gaap:RetainedEarningsMember 2008-12-31 0001377490 pina:ReverseStockSplitMember 2009-05-18 0001377490 2009-05-19 0001377490 pina:ReverseStockSplitMember 2009-05-19 0001377490 us-gaap:CommonClassAMember 2009-05-19 0001377490 us-gaap:CommonStockMember 2009-05-14 2009-05-19 0001377490 us-gaap:CommonClassAMember 2009-05-14 2009-05-19 0001377490 2009-01-01 2009-12-31 0001377490 us-gaap:CommonStockMember 2009-01-01 2009-12-31 0001377490 us-gaap:CommonClassAMember 2009-01-01 2009-12-31 0001377490 us-gaap:CommonClassAMember 2009-01-01 2009-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2009-01-01 2009-12-31 0001377490 us-gaap:RetainedEarningsMember 2009-01-01 2009-12-31 0001377490 2009-12-31 0001377490 us-gaap:CommonStockMember 2009-12-31 0001377490 us-gaap:CommonClassAMember 2009-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0001377490 us-gaap:RetainedEarningsMember 2009-12-31 0001377490 2010-01-01 2010-12-31 0001377490 us-gaap:RetainedEarningsMember 2010-01-01 2010-12-31 0001377490 2010-12-31 0001377490 us-gaap:CommonStockMember 2010-12-31 0001377490 us-gaap:CommonClassAMember 2010-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001377490 us-gaap:RetainedEarningsMember 2010-12-31 0001377490 2011-07-01 2011-09-30 0001377490 2011-01-01 2011-09-30 0001377490 2011-09-30 0001377490 us-gaap:CommonClassAMember 2011-09-30 0001377490 us-gaap:CommonStockMember 2011-09-30 0001377490 2011-01-01 2011-12-31 0001377490 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001377490 us-gaap:CommonClassAMember 2011-01-01 2011-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001377490 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001377490 2011-12-31 0001377490 us-gaap:CommonStockMember 2011-12-31 0001377490 us-gaap:CommonClassAMember 2011-12-31 0001377490 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001377490 us-gaap:RetainedEarningsMember 2011-12-31 0001377490 us-gaap:CommonClassAMember 2011-12-31 0001377490 us-gaap:CommonStockMember 2011-12-31 0001377490 2012-07-01 2012-09-30 0001377490 2012-01-01 2012-09-30 0001377490 us-gaap:CommonStockMember 2012-01-01 2012-09-30 0001377490 us-gaap:CommonClassAMember 2012-01-01 2012-09-30 0001377490 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-09-30 0001377490 us-gaap:RetainedEarningsMember 2012-01-01 2012-09-30 0001377490 2012-09-30 0001377490 us-gaap:CommonStockMember 2012-09-30 0001377490 us-gaap:CommonClassAMember 2012-09-30 0001377490 us-gaap:AdditionalPaidInCapitalMember 2012-09-30 0001377490 us-gaap:RetainedEarningsMember 2012-09-30 0001377490 us-gaap:CommonClassAMember 2012-09-30 0001377490 us-gaap:CommonStockMember 2012-09-30 0001377490 pina:KineticsLtdMember 2012-09-30 0001377490 2006-09-06 2012-09-30 0001377490 pina:CompanyTrustAccountMember 2006-09-06 2012-09-30 0001377490 us-gaap:CommonClassAMember pina:CommonStockToInitialStockholdersMember 2012-11-01 0001377490 2011-06-30 0001377490 2012-06-30 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure Pinpoint Advance CORP 0001377490 --12-31 Smaller Reporting Company pina 10-Q false 2012-09-30 Q3 2012 0 15636 3851 849 7459 13318 2541 317 317 317 5267 3292 7084 9435 4458 14860 14485 20467 9792 200552 202239 268062 215037 222706 277854 313 37 313 37 313 37 -205952 -218598 -263344 0 0 0 0 16860 83 0 24917 -8140 19271582 264 0 19000986 270332 -18500 264 0 0 -18764 -64182 37 313 0 -64532 -136505 37 313 0 -136855 -205602 -218248 37 313 0 -218598 -263344 37 313 0 -263344 9435 4458 14860 0.0001 0.0001 0.0001 1000000 1000000 1000000 0 0 0 0 0 0 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 5000000 15000000 5000000 15000000 5000000 15000000 3125000 359402 3125000 359402 3125000 359402 828125 625000 3500000 359402 3125000 0 359402 0 359402 0 359402 3125000 0 -92 -100 -300 -111025 0 0 0 0 -1000 -23603 -64712 -7652 -38389 -1466064 -1732 -4293 -2250 -6057 -19603 25335 69097 10002 44746 1597692 0 0 0 0 1359678 1359678 25335 69097 10002 44746 238014 0 0 0 0 -4444 -8140 -8140 397249 0 0 0 397249 -387073 0 0 0 -387073 -45682 0 0 0 -45682 72323 72323 25335 69097 -81743 0 0 0 81743 10002 44746 0 0 0 -44746 242458 0 0 0 0 -3042 25335 69097 10002 44746 245500 -0.01 -0.02 -0.01 3484402 3484402 3484402 3484402 0 828125 0 2637788 0 2637788 0 359402 3125000 359402 3125000 359402 3125000 359402 3125000 25000 83 0 24917 17476150 201 0 17475949 0 0 0 313 -313 0 828125 0 0 2012788 0 0 359402 3125000 0 3125000 3125000 0 -20 0 20 0 0 -251 0 251 0 -203125 0 -2515598 0 100 0 0 100 0 1500000 0 0 1500000 0 -118777 0 0 0 -118777 115735 0 0 0 115735 962500 0 0 962500 0 -19981244 0 0 -19963486 -17758 0 86 0 0 -86 862212 0 0 -62 0 62 0 -625000 0 0.0001 2875000 8506963 862212 13893 58621 21343 55148 488015 -1975 1309 6423 3792 7083 -9467 -11785 4918 6610 238474 0 0 0 0 25000 0 0 0 0 151210 0 0 0 0 151210 0 0 0 0 317 0 0 0 0 210161 1500000 0 0 0 0 100 0 0 0 0 28491250 0 0 0 0 8506963 0 0 0 0 0 0 0 0 -231015 -9467 -11785 4918 6610 7459 0 0 0 0 738750 0 0 0 0 100000 0 0 0 0 862500 0 0 0 0 25205 0 0 0 0 5953 <p style="margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;"><b>NOTE 1-DISCUSSION OF THE COMPANY&#8217;S ACTIVITIES </b></p> <p style="margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Organization and activities</b>: Pinpoint Advance Corp. (the &#8220;Company&#8221;) was incorporated in Delaware on September 6, 2006, as a blank check company that was formed for the purpose of acquiring, merging with, engaging in a capital stock exchange with, purchasing all or substantially all of the assets of, or engaging in any other similar business combination with a business that has operations or facilities located in Israel or which is a company operating outside of Israel, specifically in Europe, which management believes would benefit from establishing operations or facilities in Israel, preferably in the technology sector (&#8220;Target Business&#8221;). All activity from inception (September 6, 2006) through September 30, 2012 was related to the Company&#8217;s formation and capital raising activities. The Company has selected December&#160;31 as its fiscal year end.</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company is considered to be a development stage company and as such the financial statements presented herein are presented in accordance with Statement of Financial Accounting Standards ASC 915 "Development Stage Entities" (formerly SFAS No.&#160;7).</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The registration statement for the Company&#8217;s initial public offering (&#8220;Offering&#8221;) was declared effective on April 19, 2007. On April 25, 2007, the Company completed a private placement ("Private Placement") and received net proceed of $1.5 million. The Company consummated the Offering on April 25, 2007 for net proceeds of approximately $27 million (including the over allotment).</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On October 27, 2008, the Company announced it had executed a letter of intent to effectuate a business combination with a privately-held company with its headquarters in Israel (the "LOI"). All parties to the LOI negotiated the terms of a definitive agreement and in fact, a definitive agreement (the "Agreement") was executed by all parties to the LOI. However, one of the parties to the Agreement claimed it never released its signature thereto and subsequently indicated that it no longer wished to pursue the proposed business combination.</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company believes a binding, definitive agreement was executed by all parties and on December 8, 2009, the Company and others, filed a lawsuit against Elbit Systems Holdings Ltd. ("Elbit") and others, in the Petah Tikva District Court of Israel ("Court"), for damages in the amount of NIS 37.7 million ($10 million) (the "Lawsuit").</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">At a Special Meeting held on May 15, 2009, a majority of the Company stockholders voted in favor of the proposal to remove the blank check company restrictions from the Company&#8217;s charter, thereby allowing the Company to continue its corporate existence. In accordance with stockholder approval of the Company&#8217;s proposals, on May 19, 2009 the Company effectuated the redemption of the shares of common stock issued in the Offering in an amount of $9.91 per share from the Company&#8217;s trust account and distribution of one share of new common stock for every eight Offering Shares redeemed.&#160;&#160;The stockholders also approved the creation of a new class of common stock called Class A Common Stock and exchanged each share of common stock held by the initial stockholders for five shares of Class A Common Stock. The Class A shares rights are identical to the new common shares rights</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">All the warrants issued in the Offering expired unexercised on April 19, 2011 and were canceled.</p> <p style="margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Going concern consideration </b>As indicated in the accompanying financial statements, at September 30, 2012, the Company had $7,459 in cash, current liabilities of $277,854 and working capital deficit of $262,994. Further, the Company has incurred and expects to continue to incur costs. These factors, among others, indicate that the Company may be unable to continue operations as a going concern unless further financing from related parties is consummated.</p> <p style="text-align: justify; text-indent: -0.5in; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;"><b>NOTE 2-SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </b></p> <p style="text-align: justify; text-indent: -0.5in; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Cash and Cash Equivalents</b>-Cash and cash equivalents are deposits with financial institutions as well as short-term money market instruments with maturities of three months or less when purchased. The Company did not hold any cash equivalents as of September 30, 2012.</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 27pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Trust Account</b>-The Company's restricted cash and cash equivalents was held in the Trust Account until May 19, 2009 and was invested in a money market fund. The Company recognized interest income $1,359,678 from inception (September 6, 2006) to May 19, 2009 on such money market fund, which is included in interest income on the accompanying statements of operations.</p> <p style="text-align: justify; text-indent: 27pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Concentration of Credit Risk</b>-financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents. The Company may maintain deposits in federally insured financial institutions in excess of federally insured limits. However, management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held.</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 27pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Net Income per Share</b>-Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Basic earnings per share subject to possible conversion is calculated by dividing accretion of Trust Account relating to common stock subject to possible conversion by 107,777 common shares subject to possible conversion. Diluted earnings per share reflect the additional dilution for all potentially dilutive securities such as stock warrants and options. The effect of the 1,500,000 outstanding warrants, issued in connection with the private placement described in Note 1 and the warrants issued in connection with the public offering has not been considered in the diluted net earnings per share since the warrants are contingently exercisable. The effect of the 125,000 units included in the underwriters purchase option, as described in Note 5, along with the warrants underlying such units, has not been considered in the diluted earnings per share calculation since the market price of the unit was less than the exercise price during the period.</p> <p style="text-align: justify; text-indent: 27pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Fair Value of Financial Instruments</b>-the fair values of the Company&#8217;s assets and liabilities that qualify as financial instruments under ASC 825 "Financial Instrument" (SFAS No. 107) &#8220;Disclosures about Fair Value of Financial Instrument,&#8221; approximate their carrying amounts presented in the balance sheet at September 30, 2012.</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Use of Estimates</b>-The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that effect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Income Taxes</b>-Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in future taxable or deductible amounts and are based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount expected to be realized.</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Recently Issued Accounting Standards Updates</b></p> <p style="text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company does not believe that recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p> <p style="text-align: justify; text-indent: -0.5in; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;"><b>NOTE 3-DEFFERED UNDERWRITING FEE</b></p> <p style="text-align: justify; text-indent: -0.5in; margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">In connection with the Offering, the Company entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with the underwriters in the Offering. Pursuant to the Underwriting Agreement, the Company was obligated to the underwriters for certain fees and expenses related to the Offering, including underwriting discounts of $2.2 million (with over allotment exercised). The Company paid $1.4 million, of the underwriting discount upon closing of the Offering (including the over allotment). In connection with the Offering, the Company entered into an engagement agreement (the &#8220;Engagement Agreement&#8221;) with its legal counsel in the Offering. Pursuant to the Engagement Agreement, the Company was obligated to its legal counsel for certain fees and expenses related to the Offering, including an aggregate legal fee of $250,000. The Company paid $150,000 of the legal fee upon closing of the Offering. The Company was unable to consummate a business combination within the time allotted and all deferred legal fees and deferred underwriter fees were distributed to stockholders as part of the trust distribution. As discussed in Note 1, those fees has been reclassified to the Additional Paid-in capital and will not be payable upon liquidation.</p> <p style="text-indent: -0.25in; margin: 0pt 0px 0pt 0.25in; font: 10pt times new roman, times, serif;"><b>NOTE 4- COMMITMENTS AND CONTINGENCIES </b></p> <p style="text-indent: -0.25in; margin: 0pt 0px 0pt 0.25in; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On December 8, 2009, the Company and others, filed the Lawsuit based on the following factual background:</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;"></td> <td style="width: 0.5in;">a.</td> <td style="text-align: justify;">That following a period of extensive negotiations between inter alia, the Company and Elbit, a July 2008 Letter of Intent was signed, which contemplated inter alia, the Company purchase from Elbit of 31% of Kinetics, i.e. 18,716 Ordinary Shares of Kinetics Ltd. (the "Kinetics Shares"), in the amount of $ 26 million Following said purchase, a merger between the Company and Kinetics was to be effectuated;</td> </tr> </table> <p style="margin-top: 0pt; font: 10pt times new roman, times, serif; margin-bottom: 0pt;">&#160;</p> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;"></td> <td style="width: 0.5in;">b.</td> <td style="text-align: justify;">That the Company, as a blank check company and in order to fulfill its duty to obtain timely shareholders' approval, was compelled to finalize the deal by October 18, 2008;</td> </tr> </table> <p style="margin-top: 0pt; font: 10pt times new roman, times, serif; margin-bottom: 0pt;">&#160;</p> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;"></td> <td style="width: 0.5in;">c.</td> <td style="text-align: justify;">That based on the Letter of Intent, and a belief at the time of Elbit's good faith, the Company continued negotiating;</td> </tr> </table> <p style="margin-top: 0pt; font: 10pt times new roman, times, serif; margin-bottom: 0pt;">&#160;</p> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;"></td> <td style="width: 0.5in;">d.</td> <td style="text-align: justify;">That after lengthy negotiations, a definitive agreement was finalized, and signed, in early October 2009.</td> </tr> </table> <p style="margin-top: 0pt; font: 10pt times new roman, times, serif; margin-bottom: 0pt;">&#160;&#160;</p> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;"></td> <td style="width: 0.5in;">e.</td> <td style="text-align: justify;">That Elbit's signature on the definitive agreement was withheld, based on Elbit's claim that it had "just received" information about a new order that would raise the forecast of Kinetics' profits in 2009;</td> </tr> </table> <p style="margin-top: 0pt; font: 10pt times new roman, times, serif; margin-bottom: 0pt;">&#160;</p> <table style="margin-top: 0pt; width: 100%; font: 10pt times new roman, times, serif; margin-bottom: 0pt;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.25in;"></td> <td style="width: 0.5in;">f.</td> <td style="text-align: justify;"><font style="font-family: times new roman, times, serif; color: black;">That Elbit&#8217;s remained a shareholder of Kinetics Shares after October 18, 2008.</font></td> </tr> </table> <p style="margin-top: 0pt; font: 10pt times new roman, times, serif; margin-bottom: 0pt;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Lawsuit seeks reparation for damages caused to plaintiffs as a result of defendants' lack of good faith in negotiations, and requests that the Court hold that defendants materially breached the definitive agreement, that defendants are estopped from denying that the definitive agreement was finalized, and that defendants acted with fraud, and alternatively, with recklessness. The Lawsuit also alleges that Elbit was unjustly enriched by its conduct, and that any enrichment as a result of Elbit's retention of the Kinetics Shares belongs to the Company.</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Lawsuit is in preliminary stages. On February 22, 2011, the defendants filed a Statement of Defense. Pursuant to Court suggestion, the parties have submitted their dispute to non-binding mediation, before Professor Nily Cohen. The mediation was unsuccessful and the lawsuit was referred back to the court.&#160; The Company cannot opine on the likelihood of success at the present time.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>NOTE 5-STOCKHOLDER&#8217;S EQUITY</b></p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">In the Offering, effective April&#160;19, 2007 (closed on April 25, 2007), the Company sold to the public 2,875,000 Units (the &#8220;Units&#8221; or a &#8220;Unit&#8221;) at a price of $10.00 per Unit. Each unit consisted of one share and one warrant. Each warrant entitles the holder to purchase one share of the Company's common stock at a price of $7.50. Proceeds from the initial public offering and the Private placement totaled approximately $28.5 million, which was net of approximately $1.6 million in underwriting fees and other expenses paid at closing.</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company also sold to underwriters for $100 an option to purchase up to 125,000 Units.</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On May 19, 2009 in accordance with stockholder consent, the Company effectuated the exchange and redemption of its capital stock whereby holders of stock in the Offering received one share of new common stock for eight shares held and issued one share of Class A common stock for each share of common stock purchased prior to the Offering for an aggregate of 359,402 shares of new common stock and 3,125,000 shares of Class A common stock. The class A shares rights are identical to the new common share rights.</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">All the warrants issued in the Offering expired unexercised on April 19, 2011 and were canceled.</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>NOTE 6- WARRANTS AND OPTION TO PURCHASE COMMON STOCK</b></p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company was unable to effectuate the business combination within the time allotted and the deferred underwriting discount was distributed to stockholders as part of the trust distribution. Immediately prior to the Offering the Company sold to certain of the initial stockholders 1,500,000 warrants ("Private Warrants"), for an aggregate purchase price of $1.5 million. All of the Company&#8217;s stockholders prior to the Proposed Offering (&#8220;Initial Stockholders&#8221;) agreed to vote the shares of common stock owned by them immediately before the Offering and the Private Placement in accordance with the majority of the shares of common stock voted by the public stockholders.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The public warrants, and the underwriter's unit purchase option and the warrants included in the underwriter&#8217;s unit purchase option, were not subject to net cash settlement in the event the Company is unable to maintain an effective 1933 Act registration statement.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="margin: 0pt 0px 0pt 0.5in; font: 10pt times new roman, times, serif;">All the warrants issued in the Offering expired unexercised on April 19, 2011 and were canceled.</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>NOTE 7-CAPITAL STOCK</b></p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b><i>Preferred Stock</i></b></p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company is authorized to issue up to 1,000,000 shares of Preferred Stock with such designations, voting, and other rights and preferences as may be determined from time to time by the Board of Directors.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b><i>Common Stock</i></b></p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On February 20, 2007, the number of outstanding shares decreased from 828,125 shares to 625,000 shares as a result of a reverse split of the Company's common stock.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On April 25, 2007, the number of outstanding shares was 3,125,000 after consummating the Offering.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On May 2, 2007, the number of outstanding shares was 3,500,000 after exercising the over-allotment option.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">On May 19, 2009, the number of outstanding shares was decreased from 3,500,000 to 359,402 as a result of a reverse split of 8 to 1 of the common stock issued in the Offering and as a result of cancellation of common stock by the initial stockholders.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">As of November [ ], 2012 there were 359,402 shares of common stock, par value $.0001 per share, issued and outstanding.</p> <p style="text-indent: 0.5in; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b><i>Class A Common Stock</i></b></p> <p style="margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-align: justify; text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">As of November [ ], 2012 there were 3,125,000 shares of Class A Common Stock, par value $.0001 per share issued and outstanding..</p> <div><b>Cash and Cash Equivalents</b>-Cash and cash equivalents are deposits with financial institutions as well as short-term money market instruments with maturities of three months or less when purchased. The Company did not hold any cash equivalents as of September 30, 2012.</div> <div><b>Trust Account</b>-The Company's restricted cash and cash equivalents was held in the Trust Account until May 19, 2009 and was invested in a money market fund. The Company recognized interest income $1,359,678 from inception (September 6, 2006) to May 19, 2009 on such money market fund, which is included in interest income on the accompanying statements of operations.</div> <div><b>Concentration of Credit Risk</b>-financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents. The Company may maintain deposits in federally insured financial institutions in excess of federally insured limits. However, management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held.</div> <div><b>Net Income per Share</b>-Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Basic earnings per share subject to possible conversion is calculated by dividing accretion of Trust Account relating to common stock subject to possible conversion by 107,777 common shares subject to possible conversion. Diluted earnings per share reflect the additional dilution for all potentially dilutive securities such as stock warrants and options. The effect of the 1,500,000 outstanding warrants, issued in connection with the private placement described in Note 1 and the warrants issued in connection with the public offering has not been considered in the diluted net earnings per share since the warrants are contingently exercisable. The effect of the 125,000 units included in the underwriters purchase option, as described in Note 5, along with the warrants underlying such units, has not been considered in the diluted earnings per share calculation since the market price of the unit was less than the exercise price during the period.</div> <div><b>Fair Value of Financial Instruments</b>-the fair values of the Company&#8217;s assets and liabilities that qualify as financial instruments under ASC 825 "Financial Instrument" (SFAS No. 107) &#8220;Disclosures about Fair Value of Financial Instrument,&#8221; approximate their carrying amounts presented in the balance sheet at September 30, 2012.</div> <div><b>Use of Estimates</b>-The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that effect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</div> <div><b>Income Taxes</b>-Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in future taxable or deductible amounts and are based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount expected to be realized.</div> <p style="text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;"><b>Recently Issued Accounting Standards Updates</b></p> <p style="text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">&#160;</p> <p style="text-indent: 24.5pt; margin: 0pt 0px; font: 10pt times new roman, times, serif;">The Company does not believe that recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</p> 1500000 27000000 9.91 262994 107777 1500000 125000 2200000 1400000 250000 150000 0.31 18716 26000000 2875000 10.00 7.50 28500000 1600000 100 125000 1500000 1500000 0 0 0 0 18438650 0001377490pina:AfterExercisingOverAllotmentOptionMember2007-05-02 0001377490us-gaap:CommonStockMember2012-11-08 0001377490us-gaap:CommonClassAMember2012-11-08 359402 3125000 0.0001 0.0001 00013774902009-05-152009-05-19 8 to 1 0001377490pina:BeforeStockSplitAdjustmentMember2007-02-20 0001377490pina:AfterStockSplitAdjustmentMember2007-02-20 828125 625000 3125000 3500000 0001377490pina:BeforeStockSplitAdjustmentMember2009-05-19 0001377490pina:AfterStockSplitAdjustmentMember2009-05-19 3500000 359402 359402 3125000